Compare WST & EME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WST | EME |
|---|---|---|
| Founded | 1923 | 1987 |
| Country | United States | United States |
| Employees | N/A | 25000 |
| Industry | Medical/Dental Instruments | Engineering & Construction |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.9B | 32.7B |
| IPO Year | 2004 | 1994 |
| Metric | WST | EME |
|---|---|---|
| Price | $367.64 | $725.00 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 7 |
| Target Price | $325.86 | ★ $831.67 |
| AVG Volume (30 Days) | ★ 339.7K | 301.3K |
| Earning Date | 04-23-2026 | 04-29-2026 |
| Dividend Yield | ★ 0.30% | 0.19% |
| EPS Growth | 1.49 | ★ 30.99 |
| EPS | 4.07 | ★ 15.89 |
| Revenue | $2,886,900,000.00 | ★ $16,986,422,000.00 |
| Revenue This Year | $6.76 | $7.85 |
| Revenue Next Year | $6.22 | $7.05 |
| P/E Ratio | $89.06 | ★ $46.46 |
| Revenue Growth | 1.95 | ★ 16.62 |
| 52 Week Low | $223.83 | $564.92 |
| 52 Week High | $386.00 | $951.96 |
| Indicator | WST | EME |
|---|---|---|
| Relative Strength Index (RSI) | 66.30 | 43.51 |
| Support Level | $346.45 | $719.68 |
| Resistance Level | $367.66 | $747.78 |
| Average True Range (ATR) | 7.78 | 20.78 |
| MACD | 2.77 | -0.57 |
| Stochastic Oscillator | 87.18 | 25.32 |
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
EMCOR Group Inc is a specialty contractor in the United States and a provider of electrical and mechanical construction and facilities services, building services, and industrial services. Its services are provided to a broad range of commercial, technology, manufacturing, industrial, healthcare, utility, and institutional customers through approximately 100 operating subsidiaries. The company's operating subsidiaries are organized into reportable segments: United States mechanical construction and facilities services, which derives key revenue; United States electrical construction and facilities services; United States building services; United States industrial services; and United Kingdom building services. Geographically, its key revenue is derived from the United States.